They designed a special 3D cavity that can trap light, allowing it to bounce in specific patterns known as cavity modes. These patterns are crucial for systems involving light-matter interaction ...

According to the letter, the FDA did not agree with the proposition to include additional extended dosing intervals greater than 16 weeks. The Food and Drug Administration (FDA) has issued a ...

Patients treated with trastuzumab deruxtecan + pertuzumab had a statistically significant and clinically meaningful improvement in PFS compared with standard of care. Topline results were ...